Logo Logo
Hilfe
Hilfe
Switch Language to English

Lebas, Mathilde ORCID logoORCID: https://orcid.org/0009-0004-4464-0031; Chinigò, Giorgia ORCID logoORCID: https://orcid.org/0000-0002-3772-178X; Courmont, Evan ORCID logoORCID: https://orcid.org/0009-0008-5624-8933; Bettaieb, Louay ORCID logoORCID: https://orcid.org/0000-0002-1680-7891; Machmouchi, Amani ORCID logoORCID: https://orcid.org/0009-0001-5643-679X; Goveia, Jermaine; Beatovic, Aleksandar; Kerckhove, Job Van ORCID logoORCID: https://orcid.org/0009-0009-6273-9787; Robil, Cyril ORCID logoORCID: https://orcid.org/0000-0002-3607-244X; Angulo, Fabiola Silva; Vedelago, Mauro ORCID logoORCID: https://orcid.org/0000-0002-5886-7032; Errerd, Alina ORCID logoORCID: https://orcid.org/0009-0003-8854-6189; Treps, Lucas ORCID logoORCID: https://orcid.org/0000-0003-0735-9000; Gao, Vance ORCID logoORCID: https://orcid.org/0000-0003-4492-1154; Delgado Herrán, Hilda C. de la ORCID logoORCID: https://orcid.org/0000-0003-2506-6172; Mayeuf-Louchart, Alicia ORCID logoORCID: https://orcid.org/0000-0002-3787-7450; L’homme, Laurent ORCID logoORCID: https://orcid.org/0000-0002-5069-1837; Chamlali, Mohamed ORCID logoORCID: https://orcid.org/0000-0002-9942-1424; Dejos, Camille ORCID logoORCID: https://orcid.org/0000-0002-6841-9372; Gouyer, Valérie ORCID logoORCID: https://orcid.org/0000-0002-4223-7060; Garikipati, Venkata Naga Srikanth; Tomar, Dhanendra ORCID logoORCID: https://orcid.org/0000-0002-3144-7257; Yin, Hao ORCID logoORCID: https://orcid.org/0000-0002-0018-3228; Fukui, Hajime ORCID logoORCID: https://orcid.org/0000-0002-7652-2222; Vinckier, Stefan ORCID logoORCID: https://orcid.org/0009-0000-8301-5395; Stolte, Anneke ORCID logoORCID: https://orcid.org/0009-0004-4389-7900; Conradi, Lena-Christin ORCID logoORCID: https://orcid.org/0000-0002-9488-1018; Infanti, Fabrice; Lemonnier, Loic ORCID logoORCID: https://orcid.org/0000-0001-6200-5382; Zeisberg, Elisabeth; Luo, Yonglun ORCID logoORCID: https://orcid.org/0000-0002-0007-7759; Lin, Lin ORCID logoORCID: https://orcid.org/0000-0002-7546-4948; Desseyn, Jean-Luc ORCID logoORCID: https://orcid.org/0000-0001-6876-8049; Pickering, J. ORCID logoORCID: https://orcid.org/0000-0001-6474-3274; Kishore, Raj ORCID logoORCID: https://orcid.org/0000-0002-8168-3004; Madesh, Muniswamy ORCID logoORCID: https://orcid.org/0000-0001-6745-9092; Dombrowicz, David ORCID logoORCID: https://orcid.org/0000-0002-0485-8923; Perocchi, Fabiana ORCID logoORCID: https://orcid.org/0000-0002-1102-6500; Staels, Bart ORCID logoORCID: https://orcid.org/0000-0002-3784-1503; Pla, Alessandra Fiorio ORCID logoORCID: https://orcid.org/0000-0003-4576-1594; Gkika, Dimitra ORCID logoORCID: https://orcid.org/0000-0001-8612-0836 und Cantelmo, Anna Rita ORCID logoORCID: https://orcid.org/0000-0002-2748-264X (2024): Integrated single-cell RNA-seq analysis reveals mitochondrial calcium signaling as a modulator of endothelial-to-mesenchymal transition. In: Science Advances, Bd. 10, Nr. 32, eadp6182 [PDF, 5MB]

Abstract

Endothelial cells (ECs) are highly plastic, capable of differentiating into various cell types. Endothelial-to-mesenchymal transition (EndMT) is crucial during embryonic development and contributes substantially to vascular dysfunction in many cardiovascular diseases (CVDs). While targeting EndMT holds therapeutic promise, understanding its mechanisms and modulating its pathways remain challenging. Using single-cell RNA sequencing on three in vitro EndMT models, we identified conserved gene signatures. We validated original regulators in vitro and in vivo during embryonic heart development and peripheral artery disease. EndMT induction led to global expression changes in all EC subtypes rather than in mesenchymal clusters. We identified mitochondrial calcium uptake as a key driver of EndMT; inhibiting mitochondrial calcium uniporter (MCU) prevented EndMT in vitro, and conditional Mcu deletion in ECs blocked mesenchymal activation in a hind limb ischemia model. Tissues from patients with critical limb ischemia with EndMT features exhibited significantly elevated endothelial MCU. These findings highlight MCU as a regulator of EndMT and a potential therapeutic target.

Dokument bearbeiten Dokument bearbeiten